Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 1,850,000 shares, a decrease of 7.5% from the October 31st total of 2,000,000 shares. Based on an average daily volume of 190,100 shares, […]
StockNews.com upgraded shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) to a sell rating in a research note published on Wednesday morning. ATNM has been the subject of several other reports. HSBC began coverage on Actinium Pharmaceuticals in a research report on Wednesday, September 6th. They set a buy rating and a $11.60 price target […]
StockNews.com assumed coverage on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright cut their price target on Actinium Pharmaceuticals from $53.00 to $50.00 and set a buy rating on the stock in […]
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Equities researchers at William Blair decreased their Q3 2023 earnings per share estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, August 15th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.73) per share for the quarter, […]